2′‐Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

2′‐Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76

Published:2018-09-19 Issue:12 Volume:57 Page:1751-1762
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Molecular Carcinogenesis

Author:

Singhal Jyotsana¹²,Chikara Shireen¹,Horne David²,Salgia Ravi¹,Awasthi Sanjay³,Singhal Sharad S.¹^ORCID

Affiliation:

1. Department of Medical OncologyBeckman Research Institute of City of HopeComprehensive Cancer Center and National Medical CenterDuarteCalifornia

2. Department of Molecular MedicineBeckman Research Institute of City of HopeComprehensive Cancer Center and National Medical CenterDuarteCalifornia

3. Department of Internal MedicineTexas Tech University Health Sciences CenterLubbockTexas

Funder

U.S. Department of Defense

Beckman Research Institute, City of Hope

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.22894

Reference46 articles.

1. Cancer treatment and survivorship statistics, 2012

2. Novel targets and therapies for a personalized approach

3. Targeted Therapy for Breast Cancer

4. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

5. Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Products for the Prevention, Treatment and Progression of Breast Cancer;Cancers;2023-05-30

2. Analysis of 2′-hydroxyflavanone (2HF) in mouse whole blood by HPLC–MS/MS for the determination of pharmacokinetic parameters;Frontiers in Chemistry;2023-03-09

3. Prognostic significance of natural products against multidrug tumor resistance;Cancer Letters;2023-03

4. Opportunities, obstacles and current challenges of flavonoids for luminal and triple-negative breast cancer therapy;European Journal of Medicinal Chemistry Reports;2022-12

5. Fixing the GAP: The role of RhoGAPs in cancer;European Journal of Cell Biology;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3